A Comparative Clinical Study Of Jalaukavacharna With And Without Local Application Of Mahavajraka Tail In The Management Of Sirajgranthi W.S.R To Varicose Veins

Dayanand Ayurvedic College1 个研究点分布在 1 个国家目标入组 60 人开始时间: 2025年2月5日最近更新: 2024年12月27日

试验速览

阶段: 2 期
状态: 尚未招募
发起方
入组人数: 60
试验地点: 1
主要终点: Following symptoms will be assessed for the reduction in their severity:

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The total of 60 patients will be selected who are between age group of 18 to 65 years of either sex who are diagnosed with Sirajgranthi on the basis of sign and symptoms. Patients will be divided into two groups (Trial Group A and Trial Group B). Group A will be intervene with Jalaukavcharna and Group B will be intervene with Jalaukavcharna along with local application of Mahavajraka Tail and conduct a clinical study - To evaluate the efficacy of Jalaukavcharna in the management of Sirajgranthi w.s.r to Varicose Veins,To evaluate the efficacy of Jalaukavcharna along with local application of Mahavajraka Tail in the management of Sirajgranthi w.s.r to Varicose Veins, To evaluate the difference of efficacy of Jalaukavcharna with and without local application of Mahavajraka Tail in the management of Sirajgranthi w.s.r to Varicose Veins.

研究设计

研究类型: Interventional
分配方式: Randomized
盲法: None

入排标准

年龄范围: 18.00 Year(s) 至 65.00 Year(s)（—）
性别: All

入选标准

•Subjects with classical signs and symptoms of Sirajgranthi.
•Subjects between 18 years to 65 years.
•Any gender willing and able to participate in the study.

排除标准

•Subjects having chronicity more than 10 years.
•Pregnant women and lactating women will be excluded.
•Subjects having any other major complicated diseases like Diabetes Mellitus, Cardiac Diseases, Tuberculosis, HIV, HCV, HBsAg.
•Subjects diagnosed with Venous Ulcers, Deep Vein Thrombosis, Anemia, Thrombocytopenia will be excluded.